Dendritic cells: Versatile controllers of the immune system

Nature Medicine

Volumn 13, Issue 10, 2007, Pages 1155-1159

  Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

ALLERGY; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELL ACTIVITY; CELL CLONING; CELLULAR IMMUNITY; DENDRITIC CELL; GRAFT REJECTION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; MOLECULAR RECOGNITION; NOTE; PRIORITY JOURNAL; ANIMAL; ARTICLE; AWARDS AND PRIZES; BIOLOGICAL MODEL; IMMUNOLOGY; T LYMPHOCYTE; UNITED STATES;

ALLERGY AND IMMUNOLOGY; ANIMALS; AWARDS AND PRIZES; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES; UNITED STATES;

EID: 34948895988     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1643     Document Type: Note

References (73)

1. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
2. Lanzavecchia, A. & Sallusto, F. Regulation of T cell immunity by dendritic cells. Cell 106, 263-266 (2001).
3. Moser, M. Dendritic cells in immunity and tolerance - do they display opposite functions? Immunity 19, 5-8 (2003).
4. Pulendran, B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J. Immunol. 174, 2457-2465 (2005).
5. Trombetta, E.S. & Mellman, I. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23, 975-1028 (2005).
6. Burnet, F.M. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust. J. Sci. 20, 67-69 (1957).
7. Lederberg, J. Genes and antibodies. Science 129, 1649-1653 (1959).
8. Brack, C., Hirama, M., Lenhard-Schuller, R. & Tonegawa, S. A complete immunoglobulin gene is created by somatic recombination. Cell 15, 1-14 (1978).
9. Nussenzweig, M.C. et al. Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu. Science 236, 816-819 (1987).
10. Nossal, G.J.V., Abbot, A., Mitchell, J. & Lummus, Z. Antigen in immunity. XV. Ultrastructural features of antigen capture in primary and secondary lymphoid follicles. J. Exp. Med. 127, 277-296 (1968).
11. Unanue, E.R. & Cerottini, J.-C. The immunogenicity of antigen bound to the plasma membrane of macrophages. J. Exp. Med. 131, 711-726 (1970).
12. Cohn, Z.A. The macrophage - versatile element of inflammation. In The Harvey Lectures 1981-1982, Series 77 63-80 (Academic Press, New York, 1983).
13. Steinman, R.M. & Cohn, Z.A. The interaction of soluble horseradish peroxidase with mouse peritoneal macrophages in vitro. J. Cell Biol. 55, 186-204 (1972).
14. Steinman, R.M. & Cohn, Z.A. The interaction of particulate horseradish peroxidase (HRP)-anti HRP immune complexes with mouse peritoneal macrophages in vitro. J. Cell Biol. 55, 616-634 (1972).
15. Mishell, R.I. & Dutton, R.W. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126, 423-442 (1967).
16. Mosier, D.E. A requirement for two cell types for antibody formation in vitro. Science 158, 1573-1575 (1967).
17. Steinman, R.M. & Cohn, Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142-1162 (1973).
18. Steinman, R.M. & Cohn, Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J. Exp. Med. 139, 380-397 (1974).
19. Steinman, R.M. & Witmer, M.D. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75, 5132-5136 (1978).
20. Nussenzweig, M.C., Steinman, R.M., Gutchinov, B. & Cohn, Z.A. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. J. Exp. Med. 152, 1070-1084 (1980).
21. Steinman, R.M., Gutchinov, B., Witmer, M.D. & Nussenzweig, M.C. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J. Exp. Med. 157, 613-627 (1983).
22. Van Voorhis, W.C. et al. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J. Exp. Med. 158, 174-191 (1983).
23. Inaba, K., Steinman, R.M., Van Voorhis, W.C. & Muramatsu, S. Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and man. Proc. Natl. Acad. Sci. USA 80, 6041-6045 (1983).
24. Inaba, K. & Steinman, R.M. Protein-specific helper T lymphocyte formation initiated by dendritic cells. Science 229, 475-479 (1985).
25. Schuler, G. & Steinman, R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161, 526-546 (1985).
26. Romani, N. et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169, 1169-1178 (1989).
27. Steinman, R.M. Dendritic cells: from the fabric of immunology. Clin. Invest. Med. 27, 231-236 (2004).
28. Steinman, R.M. Dendritic cells: understanding immunogenicity. Eur. J. Immunol. (in the press).
29. Zinkernagel, R.M. & Doherty, P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701-702 (1974).
30. Doherty, P.C. & Zinkernagel, R.M. H-2 compatibility is required for T-cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J. Exp. Med. 141, 502-507 (1975).
31. Zinkernagel, R.M. On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J. Exp. Med. 147, 882-896 (1978).
32. Rescigno, M. et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2, 361-367 (2001).
33. 3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254-258 (2005).
34. Chieppa, M., Rescigno, M., Huang, A.Y.C. & Germain, R.N. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203, 2841-2852 (2006).
35. Lindquist, R.L. et al. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5, 1243-1250 (2004).
36. + T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4, 579-585 (2003).
37. + T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 200, 847-856 (2004).
38. + T cell-dendritic cell interaction. Nature 440, 890-895 (2006).
39. Shakhar, G. et al. Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat. Immunol. 6, 707-714 (2005).
40. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-780 (2001).
41. + T cell tolerance. J. Exp. Med. 196, 1627-1638 (2002).
42. Liu, K. et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091-1097 (2002).
43. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11, 748-756 (2005).
44. Zammit, D.J., Cauley, L.S., Pham, Q.M. & Lefrancois, L. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22, 561-570 (2005).
45. + T cell immunity at a mucosal surface after a single dose of anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203, 607-617 (2006).
46. H2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 24, 827-838 (2006).
47. Dhodapkar, M.V., Steinman, R.M., Krasovsky, J., Münz, C. & Bhardwaj, N. Antigen specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238 (2001).
48. + T cell tolerance. Immunity 18, 713-720 (2003).
49. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204, 191-201 (2007).
50. + regulatory T cells. Proc. Natl. Acad. Sci. USA 104, 2821-2826 (2007).
51. Iwata, M. et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21, 527-538 (2004).
52. + regulatory T cells via a TGF-β? and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
53. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. & Amigorena, S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667 (2002).
54. + T cells to produce IFN-γ by an IL-12-independent but CD70-dependent mechanism in vivo. J. Exp. Med. 204, 1095-1106 (2007).
55. Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107-111 (2007).
56. Bonifaz, L.C. et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815-824 (2004).
57. + T cells in a spectrum of human MHC I haplotypes. Proc. Natl. Acad. Sci. USA 104, 1289-1294 (2007).
58. Albert, M.L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-89 (1998).
59. Savina, A. et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126, 205-218 (2006).
60. Reis e Sousa, C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483 (2006).
61. Münz, C., Steinman, R.M. & Fujii, S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202, 203-207 (2005).
62. Fujii, S., Liu, K., Smith, C., Bonito, A.J. & Steinman, R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199, 1607-1618 (2004).
63. + T cells. J. Immunol. 178, 6861-6866 (2007).
64. Feldmann, M. & Maini, R.N. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9, 1245-1250 (2003).
65. Lowes, M.A. et al. Increase in TNFα and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. USA 102, 19057-19062 (2005).
66. Means, T.K. et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407-417 (2005).
67. Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496 (2007).
68. Soumelis, V. et al. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat. Immunol. 3, 673-680 (2002).
69. Traidl-Hoffmann, C. et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J. Exp. Med. 201, 627-636 (2005).
70. Boscardin, S.B. et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 203, 599-606 (2006).
71. Waldmann, T.A. Immunotherapy: past, present and future. Nat. Med. 9, 269-277 (2003).
72. Blattman, J.N. & Greenberg, P.D. Cancer immunotherapy: a treatment for the masses. Science 305, 200-205 (2004).
73. Palade, G.E. In Les Prix Nobel 1974 (ed. Odelberg, W.) 36-37 (Imprimerie Royale P.A. Norstedt & Söner, Stockholm, 1975)